Apollo Peptide Sciences score history

Score over time

Every entry newest first

1. November 3, 2026Lowered from6.78→to6.76(-0.02)

   Market medians updated on 3 November 2026 after the NextGen Peps re-check added priced listings: pricing 6.0 to 5.9.

2. October 27, 2026Lowered from6.79→to6.78(-0.01)

   Pricing recomputed on 27 October 2026: listings added for a newly reviewed vendor (Peptide Pro) moved the market median for the same products pricing 6.1 to 6.0.

3. October 25, 2026Lowered from6.81→to6.79(-0.02)

   Pricing recomputed on 25 October 2026: listings added for a newly reviewed vendor (Pexo Labs) moved the market median for the same products: pricing 6.2 to 6.1.

4. October 24, 2026Lowered from6.82→to6.81(-0.01)

   Pricing recomputed on 24 October 2026 after Bionova Peptides' first-review prices were recorded; other vendors move only through the market medians: pricing 6.3 to 6.2.

5. October 23, 2026Lowered from6.84→to6.82(-0.02)

   Pricing recomputed on 23 October 2026 from current listings with the published rule (section E), after listings added or updated since 22 October, including a newly reviewed vendor's, moved the market median for the same products: pricing 6.4 to 6.3.

6. October 22, 2026Lowered from6.89→to6.84(-0.05)

   Claim deductions re-checked on 22 October 2026 under the published rule (only site claims contradicted by what the certificates show), each confirmed independently from primary sources. Lab 7.5 to 7.4. Note added 22 October 2026: a score on this entry was corrected from 6.83 to 6.84; it had been rounded down instead of half up.

7. October 22, 2026Raised from6.87→to6.89(+0.02)

   Operating history re-checked on 22 October 2026 under the published rule (earliest dated evidence of the business, including a never-parked store domain and the named operating company, looked up for every vendor): operating history 3.1 to 3.6.

8. October 22, 2026Raised from6.67→to6.87(+0.20)

   Re-scored on 22 October 2026 under the published rulebook, which now gives one rule for each judgement call and applies it to every vendor: shipping and refunds 5.5 to 6.5.

9. October 22, 2026Lowered from7.49→to6.67(-0.82)

   Re-scored on 22 October 2026 under our published rubric for shipping, pricing, operating history and transparency, applied to every vendor the same day: prices re-read from the vendor's site and matched by milligrams per vial, operating history from the earliest dated evidence of the business, and policies scored item by item. shipping and refunds 8.5 to 5.5, pricing 8.5 to 6.4, operating history 3.3 to 3.1, transparency 4.5 to 6.5.

10. October 22, 2026Raised from6.50→to7.49(+0.99)

    Independent testing confirmed: the vendor's Janoshik certificates were opened at the laboratory's own verification site on 22 October 2026, so the untested cap no longer applies.

11. October 22, 2026Re-checked, no change (6.50)

    Janoshik certificates confirmed on 22 October 2026 at the laboratory's own verification site, so each confirmed report now earns the key-confirmed credit under our published lab rule. Lab 6.0 to 7.5.

12. October 22, 2026Re-checked, no change (6.50)

    Lab score recalculated on 22 October 2026 under the uniform published rubric applied to every vendor: every listed product was rescored on the same fixed certificate points, with fixed deductions for certificates more than 12 months old. Lab 6.2 to 6.0.

13. October 20, 2026Raised from4.67→to6.50(+1.83)

    Lab evidence re-checked on 20 October 2026 under our coverage rule, which counts a listed product with no published certificate as zero in the lab average. Certificates cover 9 of the 9 products we list that the vendor offers for sale. Lab 2.5 to 6.2. A page-by-page re-check found a Janoshik report on all nine listed products, correcting the earlier October finding that seven had been removed; transparency 3.0 to 4.5. The score remains under the third-party cap because the reports could not be confirmed with the laboratory.

14. October 8, 2026Lowered from7.70→to4.67(-3.03)

    Seven of the eight product pages that carried a test report in July no longer do. One report remains, for IGF-1 LR3, and it could not be confirmed with the laboratory because that laboratory's public verification portal is closed to automated checks. The site still advertises third-party testing and still says readers can see the COAs, which is now a dead pointer.

15. July 23, 2026Raised from7.55→to7.70(+0.15)

    Re-audited from live COAs, verified firsthand. Found ~30 Janoshik (A-tier) reports, mass-spec confirmed with public verify keys and 99%+ purity, which disproves the earlier note that claimed no published testing evidence. Lab and transparency were both raised (listed address, LLC, guarantee). Capped below the top tier because the panels are purity and content only, with no endotoxin, sterility, or heavy-metals. Note added 22 October 2026: under the laboratory checks published that day, Janoshik Analytical is graded tier B+, and the reports we read state no identity method (check L4).